Flow cytometry detection of minimal residual disease in multiple myeloma: Lessons learned at FDA-NCI roundtable symposium. uri icon

Overview

publication date

  • December 1, 2014

Research

keywords

  • Biomarkers, Tumor
  • Flow Cytometry
  • Multiple Myeloma
  • Neoplasm, Residual

Identity

Scopus Document Identifier

  • 84920580293

Digital Object Identifier (DOI)

  • 10.1002/ajh.23831

PubMed ID

  • 25132630

Additional Document Info

volume

  • 89

issue

  • 12